SNBL USA Purchases Provantis Preclinical Solution Suite; 500 Users to be Deployed
Provantis to Assist SNBL in Delivering the Exceptional Customer Experience
CONSHOHOCKEN, PA - (BUSINESS WIRE) – February 10, 2011 - - Instem, a leading provider of early development software applications, announced today that SNBL USA has placed an order for 500 users of its Provantis® preclinical software solution suite. SNBL USA will be using the integrated Provantis solution suite to offer their biotechnology and pharmaceutical clients’ unparalleled quality in both science and service.
Based in Everett, Washington, SNBL USA is one of the nation’s leading contract research organizations (CROs) uniquely positioned to provide a broad range of preclinical study services in support of the drug development process.
SNBL USA will be accessing every module of the integrated Provantis solution suite, including Instem’s Dispense™ solution for test item control and its latest Data Import module, enabling SNBL USA to seamlessly pull a broad range of external information into Provantis such as Estrous Cycle and Bone Assessment data.
SNBL USA’s evaluation began with Instem’s Toxicology Resource Planning (TRP™) solution. Deployed as an integrated module within the Provantis suite or a stand-alone solution, TRP enables scheduling of studies, resources, equipment, animals and facilities to improve study throughput and increase up-time with less administration. Using TRP, SNBL USA will be able to initiate projects more quickly, generate more value from physical assets, and know the status of studies at all times while keeping their plans consistent across all of their facilities.
“Once we saw how comprehensive and effective their TRP solution would be for us, we expanded our evaluation to include Instem’s entire Provantis solution suite,” comments Dr. Darren Warren, SNBL USA Safety Assessment Director. “Provantis exceeded our expectations and it became clear that we needed to replace our existing software with a single integrated solution that could bring more value to our organization.”
“In addition to modern integrated solutions, we’re finding that clients want to be supported by full-service partners that are cost effective extensions of their business, working with them to achieve a common objective,” comments John Anderson-Carter, VP Sales at Instem. “Our Provantis solution will give the technological edge SNBL USA is looking for, and our people will ensure they are empowered by it, not constrained. Provantis is here to help clients with 5 users or 500, to be more productive while staying focused on their science.”
Provantis is a modern, fully integrated software system for single users and global organizations engaged in preclinical evaluation studies. Orchestrating every facet of preclinical drug safety assessment, Provantis streamlines processes and workflows with straightforward, intuitive functionality for simple or complex studies within a GLP or non-GLP environment, on-site or over the Web.
About SNBL USA, Ltd.
Headquartered in Everett, WA, SNBL USA, Ltd. is a preclinical CRO that specializes in nonhuman primate (NHP) and small animal research. Study programs range from regulatory toxicology to customized study designs and disease models. Specialized programs include reproductive toxicology, safety pharmacology, immunotoxicology and carcinogenicity.
Through a commitment to investment and excellence, SNBL USA strives to offer the biotechnology and pharmaceutical industries unparalleled quality in both science and service. For additional information call 425.407.0121 or visit www.snblusa.com.
SNBL USA is a wholly-owned subsidiary of Shin Nippon Biomedical Laboratories, Ltd. (SNBL), one of the largest CROs in Japan. Established in 1957, SNBL currently employs approximately 2,000 team members worldwide and provides full service drug development capabilities ranging from preclinical through clinical services.
Instem is a leading supplier of IT applications to the early development healthcare market, delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.
Instem’s portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.
Instem supports over 400 clients through full service offices in the United States, United Kingdom and China with additional locations in India and a full service distributor based in Japan.
Meeting clients at the intersection of investment & return™.
Gary Mitchell (US HQ)
Julie Jones (UK HQ)
Tel: +44 (0) 1785 825600